A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00586924
Recruitment Status : Completed
First Posted : January 7, 2008
Last Update Posted : August 7, 2015
Cambridge Antibody Technology
Information provided by (Responsible Party):
MedImmune LLC

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2015
  Actual Study Completion Date : May 2015

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 24, 2017
April 7, 2017
2 May 19, 2017
December 15, 2017
3 April 4, 2018
November 21, 2018
4 January 2, 2019